DrugDashboards
← Home
Manufacturing facility

Granules India Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Sy.No. 160/A, 161/E, 162, 174/A, Gagillapur Village, Dundigal-Gandimaisamma Mandal, Medchal-Malkajgiri District, Telangana 500043, India (IND)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3004097901 · DUNS 918609236

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2020-02-14
  • NAIDrug Quality Assurance2018-03-23
  • NAIDrug Quality Assurance2016-10-14
  • NAIDrug Quality Assurance2015-03-13
  • VAIDrug Quality Assurance2012-09-13
  • NAIDrug Quality Assurance2009-11-12

Drugs this plant is listed as making

20 distinct drugs across 67 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.